Media Summary: Alexander Wyatt, DPhil, University of British Columbia, Vancouver, Canada, comments on the use of a tumor-informed Alex Herrera, MD, City of Hope, Duarte, CA, discusses the growing role of Andrew A. Davis, MD, Washington University School of Medicine, St. Louis, MOm discusses future approaches in the use of ...

Implementing Ctdna Based Mrd Testing - Detailed Analysis & Overview

Alexander Wyatt, DPhil, University of British Columbia, Vancouver, Canada, comments on the use of a tumor-informed Alex Herrera, MD, City of Hope, Duarte, CA, discusses the growing role of Andrew A. Davis, MD, Washington University School of Medicine, St. Louis, MOm discusses future approaches in the use of ... Listen as Alexey Aleshin, MD, Gregory Botta, MD, PhD, Sarah Louden, and Manju George, DVM, PhD dive into tools for ... In this video, Vincent Camus, MD, Centre Henri Becquerel & LYSA Group Member, Rouen, France, shares insights into a ... Important Note: This video is for your information only. Do not use these videos for medical advice, diagnosis, or treatment.

Presenter: Dr. Alexey Aleshin, Sr Medical Director, Oncology, Natera. Dr. May Cho, from UC Davis Comprehensive Cancer Center, discusses the importance of Dr. John Marshall from Georgetown University discusses the importance of

Photo Gallery

Implementing ctDNA-based MRD testing in bladder cancer
The prognostic value of ctDNA-based MRD testing in lymphoma
Role of ctDNA in MRD
ctDNA and MRD Testing | Colorectal Cancer Care Tools for Surveillance
Exploring the use of ctDNA for monitoring MRD in patients with PMBCL
Understand ctDNA Testing
Advances in testing: A personalized, ctDNA assay for MRD detection and surveillance
ctDNA in Oncology: Transforming MRD Assessment, Disease Tracking, and Early Cancer Detection
May Cho, MD | ctDNA and MRD Testing with the Expanded Access Program
ctDNA based MRD testing in CRC | Dr. Viraj Lavingia - Program Organizer
John Marshall, MD | Importance of ctDNA and MRD Testing
2025 HOPA Conference:  Utility of Circulating Tumor DNA ctDNA Across the Cancer Care Continuum
Sponsored
Sponsored
View Detailed Profile
Implementing ctDNA-based MRD testing in bladder cancer

Implementing ctDNA-based MRD testing in bladder cancer

Alexander Wyatt, DPhil, University of British Columbia, Vancouver, Canada, comments on the use of a tumor-informed

The prognostic value of ctDNA-based MRD testing in lymphoma

The prognostic value of ctDNA-based MRD testing in lymphoma

Alex Herrera, MD, City of Hope, Duarte, CA, discusses the growing role of

Sponsored
Role of ctDNA in MRD

Role of ctDNA in MRD

Andrew A. Davis, MD, Washington University School of Medicine, St. Louis, MOm discusses future approaches in the use of ...

ctDNA and MRD Testing | Colorectal Cancer Care Tools for Surveillance

ctDNA and MRD Testing | Colorectal Cancer Care Tools for Surveillance

Listen as Alexey Aleshin, MD, Gregory Botta, MD, PhD, Sarah Louden, and Manju George, DVM, PhD dive into tools for ...

Exploring the use of ctDNA for monitoring MRD in patients with PMBCL

Exploring the use of ctDNA for monitoring MRD in patients with PMBCL

In this video, Vincent Camus, MD, Centre Henri Becquerel & LYSA Group Member, Rouen, France, shares insights into a ...

Sponsored
Understand ctDNA Testing

Understand ctDNA Testing

Important Note: This video is for your information only. Do not use these videos for medical advice, diagnosis, or treatment.

Advances in testing: A personalized, ctDNA assay for MRD detection and surveillance

Advances in testing: A personalized, ctDNA assay for MRD detection and surveillance

Presenter: Dr. Alexey Aleshin, Sr Medical Director, Oncology, Natera.

ctDNA in Oncology: Transforming MRD Assessment, Disease Tracking, and Early Cancer Detection

ctDNA in Oncology: Transforming MRD Assessment, Disease Tracking, and Early Cancer Detection

Learn about

May Cho, MD | ctDNA and MRD Testing with the Expanded Access Program

May Cho, MD | ctDNA and MRD Testing with the Expanded Access Program

Dr. May Cho, from UC Davis Comprehensive Cancer Center, discusses the importance of

ctDNA based MRD testing in CRC | Dr. Viraj Lavingia - Program Organizer

ctDNA based MRD testing in CRC | Dr. Viraj Lavingia - Program Organizer

ctDNA based MRD testing

John Marshall, MD | Importance of ctDNA and MRD Testing

John Marshall, MD | Importance of ctDNA and MRD Testing

Dr. John Marshall from Georgetown University discusses the importance of

2025 HOPA Conference:  Utility of Circulating Tumor DNA ctDNA Across the Cancer Care Continuum

2025 HOPA Conference: Utility of Circulating Tumor DNA ctDNA Across the Cancer Care Continuum

Learning Objectives: Describe

ctDNA and MRD—How, When, and on Who Do We Use It | Kristen Ciombor, MD | ESMO22 Pennsylvania

ctDNA and MRD—How, When, and on Who Do We Use It | Kristen Ciombor, MD | ESMO22 Pennsylvania

ctDNA